Out of the 30-share Sensex pack, 21 ended lower and one remained unchanged
The BSE gauge Sensex fell 73.88 points to 35,548.26 and the NSE Nifty slid 17.85 points to 10,799.85, taking cues from tumbling global shares.
In the broader market, the S&P BSE Midcap added over 1% to finish at record closing high
Firms hired additional hands to keep up with the production demand
Tata Steel was the day's worst performer in the Sensex pack, plunging 3.25 per cent, followed by Bharti Airtel at 3.05 per cent.
The Sensex was up 70 points and the Nifty was up 20 points led by SBI on robust Q2 earnings.
The broad-based NSE Nifty rose 52.80 points, or 0.50 per cent, to end at 10,530.70
Investors lost around Rs 1.57 lakh crore in market valuation on Friday.
The breadth, indicating the overall health of the market, was slightly positive
The S&P BSE Midcap and S&P BSE Smallcap indices gained 0.4% and 1%, respectively
BSE Healthcare, Oil & Gas, Consumer Durable, TECk, Power and Metal indices declined between 0.5-1%.
Metal stocks lose ground with Hindalco, Tata Steel, Sesa Sterlite down 4-10%.
The 50-share NSE Nifty shed some ground to settle at 8,699.40 points, up 40.30 points, or 0.47 per cent
For the seven months since February 2014, the benchmark index surged nearly 27%.
Broader market outperformed the frontline indices and also hit their respective all-time highs
The country must get its act on global alliances right in order to feed its fuel-hungry economy, points out Subhomoy Bhattacharjee.
Sensex lost 76 points to end at 25,589 while Nifty shed 23 points to end at 7,649.
At the close, the 50-share NSE Nifty was at 8,611.15, up 19.90 points, or 0.23 per cent, after moving between 8,637.15 and 8,555.20.
Inflation in India probably edged up in October as food prices climbed while weak demand is expected to have hurt factory output growth.
BSE Smallcap index outperformed the frontline indices to rise 0.6%, while the BSE Midcap was flat
ITC, Sun Pharma, Cipla and Tata Steel were top gainers on BSE Sensex
The market breadth, indicating the overall health of the market turned negative from positive
Covering-up of short positions ahead of Thursday's expiry of August series in the derivatives segment gave equities a slight push
It is the rupee's biggest single-day gain this year.
Next set of Q4 FY16 earnings, progress of monsoon along with election poll outcome will dictate market trend this week
The NSE Nifty went past the 8,600-mark for the first time since November 1.
Stock specific action is seen with some of the prominent companies posting their quarterly numbers.
The trading range for the Spot USD/INR pair is expected to be within 66.20 to 67.00.
The primary market showed some signs of life in a busy day.
The broader Nifty too fell for the second straight session and closed with a loss of over 62 points, or 0.54 per cent, at 11,520.30, after hovering between 11,496.85 and 11,602.55.
Snapping its 3-day winning spree against the American currency, the rupee on Wednesday dropped by 21 paise to end at 66.64 on fag-end dollar demand from banks and importers despite a sharp rally in domestic equities.
Hoard cash. There will be plenty of time and opportunity at far lower levels, warns Sonali Ranade in her weekly Market Notes
Workers had stopped production lines to protest a delay in salary hikes after 10 months of negotiations.
Good foreign capital inflows failed to restrict the rupee's fall against the dollar
Sun Pharma dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016
The 50-share NSE Nifty slipped below the 8,200-mark to touch a low of 8,154.45, but settled at 8,170.80, down 90.95 points, or 1.10 per cent
The index went below the crucial 50 mark.
Markets extended gains for the fourth consecutive day tracking gains in banks, capital goods and oil and gas majors.
The NSE 50-share index, after moving between 10,469.90 and 10,395.25, finally concluded at 10,458.65, up 41.50 points
The broader NSE index has fallen about 0.9% as investors wait for corporate results
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances